Covered recipient · General Payments record
AMBIKA P ASHRAF
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2019–2025
$39,401.48
- Reported across 64 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $12,478.00 | 3 |
| Honoraria | $2,725.00 | 2 |
| Food and Beverage | $388.24 | 3 |
| Travel and Lodging | $364.15 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $10,148.37 | 4 |
| Regeneron Pharmaceuticals, Inc. | $2,860.00 | 2 |
| CHIESI USA, INC. | $2,725.00 | 2 |
| SANOFI-AVENTIS U.S. LLC | $149.08 | 1 |
| Neurocrine BioSciences, Inc. | $72.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Chiesi USA, Inc. | $300.00 | 02/18/2025 | Honoraria | Undisputed | 06/30/2026 | 1242156351 | CMS |
| Chiesi USA, Inc. | $2,425.00 | 05/01/2025 | Honoraria | Undisputed | 06/30/2026 | 1242156353 | CMS |
| GENZYME CORPORATION | $166.22 | 10/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233569015 | CMS |
| GENZYME CORPORATION | $9,618.00 | 10/03/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233569020 | CMS |
| GENZYME CORPORATION | $59.27 | 10/03/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1233569027 | CMS |
| GENZYME CORPORATION | $304.88 | 10/04/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1233569023 | CMS |
| Neurocrine BioSciences, Inc. | $72.94 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242969456 | CMS |
| Regeneron Pharmaceuticals, Inc. | $715.00 | 10/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1213235309 | CMS |
| Regeneron Pharmaceuticals, Inc. | $2,145.00 | 10/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1213235311 | CMS |
| SANOFI-AVENTIS U.S. LLC | $149.08 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233568806 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.